Professor of Pharmaco- and Device Epidemiology
CSM, NDORMS, University of Oxford
University of Oxford
Oxford, United Kingdom
I am an academic clinician trained as a pharmaco-epidemiologist at University of Oxford and the London School of Hygiene and Tropical Medicine.
I currently work as a Professor of Pharmaco- and Device Epidemiology at the Centre for Statistics in Medicine (University of Oxford), where I lead a team of >15 staff focussed on real world evidence and pharmaco- and device epidemiology
I am interested in clinically relevant research and the generation of reliable and important evidence that can improve people's health
AMGEN (Consultant/Advisory Board, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received, DPA's department has received fees for speaker services and advisory board membership.)Astellas (Consultant/Advisory Board, His department has received advisory or consultancy fees from Astellas)Astra Zeneca (Consultant/Advisory Board, DPA's department has received fees for consultancy services.)Chesi-Taylor (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)EMA (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Janssen (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programmes organised by DPA's department and open for external participants organized by his department outside submitted work)Johnson, and Johnson (Consultant/Advisory Board, His department has received advisory or consultancy fees from Johnson, and Johnson)Les Laboratoires Servier (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Novartis (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received, Prof. Prieto-Alhambra’s research group has received grant support from Novartis)UCB Biopharma (Consultant/Advisory Board, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received, DPA's department has received fees for consultancy services.)
Friday, August 26, 2022
6:00 PM – 6:15 PM CEST
Saturday, August 27, 2022
8:30 AM – 8:45 AM CEST
Saturday, August 27, 2022
8:30 AM – 8:45 AM CEST
Saturday, August 27, 2022
10:00 AM – 11:30 AM CEST
Saturday, August 27, 2022
1:15 PM – 1:20 PM CEST
Sunday, August 28, 2022
9:00 AM – 9:15 AM CEST
Sunday, August 28, 2022
8:30 AM – 10:00 AM CEST
Sunday, August 28, 2022
2:45 PM – 3:00 PM CEST
Sunday, August 28, 2022
2:30 PM – 2:45 PM CEST